Silicon Valley might grab all the headlines, but New York isn't far behind as America's number-two tech hub. Grand Central Tech's Matt Harrigan joins Cheddar to discuss what it will take to bring big tech to the Big Apple. He shares his experience building an incubator for over 100 companies sharing 100,000 square feet of space in Manhattan.
Harrigan considers the various benefits New York has going for it as a potential technology capital. He reveals that New York's biggest unicorn of 2016 wasn't a start-up, but rather the Broadway musical "Hamilton." Harrigan uses this example as evidence that the city's diversity and culture give it a leg up on other metropolitan areas.
Finally, Grand Central Tech's co-founder and general manager discusses the company's focus on diversity. He says 50% of the platform's companies are female founded, and nearly 30% were started by veterans or persons of color. He explains how this refutes tech's reputation as a monochromatic boys' club.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
